SynthesisFrontiers in oncology2025

The effect of tislelizumab on complete and pathological complete response in non-small cell lung cancer: a systematic review and meta-analysis.

Qian Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.